OKLAHOMA CITY — Syringes of drugs readied for the second of planned back-to-back executions in Oklahoma this week will be tested as part of an investigation into the first execution, which was halted after the inmate convulsed and tried to lift his head.
Oklahoma’s attorney general’s office says said the Department of Corrections saved the lethal drugs set aside for the second execution, which was stayed for two weeks, after the execution of Clayton Lockett went awry Tuesday night.
President Barack Obama called the incident “deeply troubling” and said he’s asked his attorney general for a review of the death penalty’s application.
Lockett died 43 minutes after his execution began of an apparent heart attack as Oklahoma used a new drug combination for the first time in the state.
Officials said Friday the autopsy report on Lockett will take two to three months to complete. Department of Public Safety spokesman Capt. George Brown said the autopsy, being performed in Dallas, is expected to be finished in eight to 12 weeks. Lockett’s body arrived in Dallas about 12:30 a.m. Thursday.
Gov. Mary Fallin had called on Wednesday for an investigation of Lockett’s execution to be conducted by the state’s Department of Public Safety. She has issued a stay until May 13 for Warner’s execution, but said Thursday she was willing to issue a 60-day stay for Warner, the longest allowed under state law, if needed to complete the inquiry.
If 60 days is not adequate, Oklahoma’s attorney general has said he would request an additional stay from the courts to ensure no executions are carried out until the review is complete.
The drugs intended for Warner were never used. Assistant Attorney General Kindanne Jones said in a letter Friday that attorneys for Lockett and Warner may have access to the drugs if any are left over after the state’s analysis is complete.